C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/1998
10/13/1998	US5821231 Treatment of immunoinflammatory conditions
10/13/1998	US5820849 Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes
10/13/1998	US5820845 Somatostatin-derived peptides for imaging and therapeutic uses
10/08/1998	WO1998029562A3 Improved substrates for human cytomegalovirus protease
10/08/1998	WO1998028268A3 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
10/07/1998	EP0868716A1 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities
10/07/1998	EP0868526A1 NOVEL PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-$g(b)-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH 2?
10/07/1998	EP0868429A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/07/1998	EP0868428A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity
10/07/1998	EP0837875A4 Inhibitors of farnesyl-protein transferase
10/07/1998	EP0621867B1 New endothelin antagonists and their preparation
10/07/1998	CN1195354A New thrombin inhibitors their preparation and use
10/06/1998	US5817811 Amidation of the correspond esterified amine compound with a carboxylated nucleotide base
10/06/1998	US5817785 Methods of producing nucleic acid ligands
10/06/1998	US5817757 Inhibitors of peptide binding to MHO class II proteins
10/06/1998	US5817749 Cyclic pentapeptides
10/06/1998	US5817303 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
10/06/1998	CA2168131C Tetrahydro-1h-benzazepinones containing acid surrogates
10/01/1998	WO1998042735A1 Novel monomer elements for marking peptidic nucleic acids
10/01/1998	WO1998042732A1 Mu-opiate receptor peptides
10/01/1998	WO1998042656A1 Novel compounds
10/01/1998	WO1998042342A1 Thrombin inhibitors
10/01/1998	DE19712530A1 Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren New monomer to mark peptide nucleic acids
10/01/1998	CA2283704A1 Thrombin inhibitors
09/1998
09/30/1998	EP0866878A1 Detection of mammary tumor virus-like sequences in human breast cancer
09/30/1998	EP0866805A1 PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
09/30/1998	EP0866705A1 Fibrinogen receptor antagonists
09/30/1998	EP0866698A1 Hemoregulatory compounds
09/30/1998	EP0627929B1 Inhibitors of thrombosis
09/30/1998	EP0598899B1 Liquid phase synthesis of peptides and peptide derivatives
09/30/1998	CN1040003C Process for preparing trifluoromethylktone derivatives
09/29/1998	US5814611 Pharmaceutical for the therapy of immune deficiency conditions
09/29/1998	US5814610 Tetrapeptides to hexapeptides with specific amino acid sequences for wound healing agents and osteoblast or fibroblastic growth promoters
09/29/1998	US5814298 Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
09/29/1998	US5814297 Amino acid residues covalently linked to a radioisotope
09/29/1998	CA2069352C Method of preparing .alpha.-l-aspartyl-l-phenylalaline methyl ester hydrochloride
09/29/1998	CA2020474C Antiinflammatory and/or antiallergic composition
09/24/1998	WO1998041537A1 Peptide-peptoid metal complexes
09/24/1998	WO1998041223A1 N-methyl-d-aspartate receptor channel blockers and method for identifying such
09/23/1998	EP0866075A2 Method to treat microbial infections by uncoupling of phosphotransferase system and appropriate agents therefor
09/23/1998	EP0866074A1 Novel nk374186 analogues or pharmacologically acceptable salts thereof
09/23/1998	EP0866073A1 Novel dipeptide derivatives and sweetening agents
09/23/1998	EP0865446A1 Agents for promoting bone formation
09/23/1998	EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
09/23/1998	EP0865339A1 Metalloproteinase inhibitors
09/23/1998	EP0865292A1 Compositions and methods for the prevention and treatment of oral mucositis
09/23/1998	CN1193998A Bioprocess for producing dipeptide based compounds
09/23/1998	CN1193979A Macrolides
09/23/1998	CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
09/23/1998	CN1193977A Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
09/22/1998	US5811548 Tri-and tetracyclic compounds
09/22/1998	US5811441 Inhibition of platelet aggregation; treatment of autoimmune diseases
09/22/1998	US5811440 Anticarcinogenic actinomadura culture products
09/22/1998	US5811424 Control of downy mildew, late blight
09/22/1998	US5811402 Anticoagulants, thrombin inhibitors
09/22/1998	US5811401 A cyclic pentosidine-arginine-lysine dipeptide for treating, analyzing the diabetes, renal disorder and aging
09/22/1998	US5811400 Analgesics, immunosuppressive agents
09/22/1998	US5811399 Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
09/22/1998	US5811398 Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues
09/22/1998	US5811394 Technetium-99m labeled polypeptides for imaging
09/22/1998	US5811391 Cyclic CS-1 peptidomimetics, compositions and methods of using same
09/22/1998	US5811389 Inhibiting platelet aggregation; blood disorders
09/22/1998	US5811387 Enzyme resistant oligo- or poly-peptoid which may selectively bind to polypeptide or effector molecule; mimetics, peptoid libraries
09/22/1998	CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present
09/22/1998	CA2056911C Hiv protease inhibitors
09/22/1998	CA2004028C Condensed benzene derivative
09/18/1998	CA2232347A1 Novel dipeptide derivatives and sweetening agents
09/17/1998	WO1998040738A1 Prostate specific antigen substrates
09/17/1998	WO1998040400A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus
09/17/1998	WO1998040092A1 Dolastatin-15 derivatives in combination with taxanes
09/17/1998	WO1998039979A1 Sweetener composition improved in taste
09/17/1998	CA2297164A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus
09/17/1998	CA2284137A1 Prostate specific antigen substrates
09/16/1998	EP0863916A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
09/16/1998	EP0863915A1 ACYLATED ENOL DERIVATIVES OF $g(a)-KETOESTERS AND $g(a)-KETOAMIDES
09/16/1998	EP0863900A1 Process for the preparation of a growth hormone secretagogue
09/16/1998	EP0863885A2 Novel macrocyclic compounds as metalloprotease inhibitors
09/16/1998	EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
09/16/1998	EP0863764A1 Method for analyzing isomers of enalapril and enalaprilat
09/16/1998	EP0863749A2 Complex cationic lipids
09/16/1998	EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
09/16/1998	EP0755374A4 Process for peptide segment condensation
09/16/1998	EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors
09/16/1998	CN1193325A Cell adhension inhibitors
09/16/1998	CN1193316A New cationic and polycationic amphiphiles, reagent containing same and their use
09/16/1998	CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist
09/15/1998	US5808097 Proline derivatives
09/15/1998	US5808029 Genetic engineering
09/15/1998	US5807985 Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
09/15/1998	US5807891 Antiviral ethers of aspartate protease substrate isosteres
09/15/1998	US5807879 Biotinidase-resistant biotinylated compound and methods of use thereof
09/15/1998	US5807875 Obesity therapy
09/15/1998	US5807830 Method for treatment of purulent inflammatory diseases
09/15/1998	US5807829 Serine protease inhibitor--tripeptoid analogs
09/15/1998	US5807819 Using an oligopeptide
09/15/1998	US5807537 Medical diagnosis
09/15/1998	CA2146414C Treatment of h. pylori infections
09/11/1998	WO1998039359A1 Dimeric cationic lipids on dicystine basis
09/11/1998	WO1998039358A1 Oligomeric cationic lipids
09/11/1998	WO1998039024A1 Selective mmp inhibitors having reduced side-effects

1 ... 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 ... 307